Eric Lin

Eric Lin is a Process Development Associate Scientist at LEXEO Therapeutics, having started in June 2022, after previously serving as a Process Development Intern. Prior to this role, Eric gained experience as a MSAT and QC Intern at Novo Nordisk from May 2021 to August 2021. Eric holds a Bachelor of Engineering in Biological and Biochemical Engineering from the Thayer School of Engineering at Dartmouth, completed in June 2022, and a Bachelor of Arts in Biochemistry from Vassar College, obtained in June 2021.